Document:

Exhibit 10.16

 

AVANT DIAGNOSTICS INC.

RESTRICTED STOCK GRANT AGREEMENT

 

THIS RESTRICTED STOCK
GRANT AGREEMENT (this “Agreement”) is made as of June 2, 2017 (the “Issue Date”),
by and between Avant Diagnostics Inc., a Nevada corporation (the “Company”) and Gregg Linn (“Recipient”).

 

1. Grant
of Shares.

 

1.1 Grant.
Recipient hereby acknowledges receipt of, and the Company hereby grants to Recipient, 15,000,000 shares of the Company’s
Common Stock (the “Shares”).

 

1.2 Consideration.
The Shares granted in accordance with Section 1.1 above are being issued to Recipient in consideration for services rendered as
an officer and director of the Company through the date of this Agreement. The Company hereby acknowledges receipt of adequate
consideration for the Shares.

 

1.3 Delivery
of Certificates. As soon as practicable after the Issue Date, the Company shall deliver a certificate evidencing the Shares
to Recipient. The Recipient acknowledges that the Company shall place a stop order on the Shares with the Company’s transfer
agent until any applicable portion of the Shares have vested in accordance with Section 2 below.

 

2. Vesting.
The Shares will become vested over a three (3) year period beginning from the date of this Agreement as follows: One Million
Two Hundred and Fifty Thousand Shares (1,250,000) Shares will vest quarterly on each of January 1, April 1, July 1 and
October 1 of each year, beginning with the quarter ended June 30, 2017, until all of the Shares have become fully vested.

 

3. Securities
Law Compliance.

 

3.1 No
Additional Interest or Further Obligations. Recipient hereby represents and warrants that upon execution and delivery of this
Agreement by the parties, he will not be entitled to any additional interest in the Company or its business, assets or properties
other than the Shares issuable to Recipient hereunder.

 

3.2 Investment
Representations. In connection with the acquisition of the Shares, Recipient represents to the Company the following:

 

(a) Investment.
Recipient is acquiring the Shares to be issued to Recipient for investment for Recipient’s own account and not with the view
to, or for resale in connection with, any distribution, assignment or resale within the meaning of the Securities Act of 1933,
as amended (the “Securities Act”), to others and no other person has a direct or indirect beneficial
interest, in whole or in part, in such Shares. Recipient understands that the Shares to be issued to Recipient have not been and
will not be registered under the Securities Act or under the laws of any other state of the United States in reliance upon specific
exemptions therefrom which depend upon, among other things, the bona fide nature of the investment intent as expressed herein and
in any other representations, warranties or information provided by Recipient to the Company under this Agreement.

 

     

     

    

 

(b) Restrictions
on Transfer. Recipient acknowledges that the Shares to be issued to Recipient must be held indefinitely unless subsequently
registered and qualified under the Securities Act or unless an exemption from registration and qualification is otherwise available.
In addition, Recipient understands that the certificate representing the Shares will be imprinted with a legend which prohibits
the transfer of such Shares unless they are sold in a transaction in compliance with the Securities Act or are registered and qualified
or such registration and qualification are not required in the opinion of counsel acceptable to the Company.

 

(c) Rule 144.
Recipient is familiar with the provisions of Rules 144 and 701, under the Securities Act, which, in substance, permit limited public
resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of
such issuer), in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer
qualifies under Rule 701 at the time of issuance of the securities, such issuance will be exempt from registration under the Securities
Act.

 

(d) Relationship
to the Company; Experience. Recipient has a preexisting business relationship with the Company and by reason of Recipient’s
business or financial experience, has the capacity to protect Recipient’s own interests in connection with Recipient’s
acquisition of the Shares to be issued to Recipient hereunder. Recipient has such knowledge and experience in financial, tax and
business matters to enable Recipient to utilize the information made available to Recipient and/or them in connection with the
acquisition of the Shares to evaluate the merits and risks of the prospective investment and to make an informed investment decision
with respect thereto.

 

(e) Not
Registered Under Securities Act. Recipient understands that the grant of the Shares has not been registered under the Securities
Act in reliance upon exemption therefrom. Recipient was not granted, offered or sold the Shares, directly or indirectly, by means
of any form of general solicitation or general advertisement, including the following: (i) any advertisement, article, notice
or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; or (ii) any
seminar or meeting whose attendees had been invited by general solicitation or general advertising.

 

(f) Access
to Data. Recipient acknowledges that during the course of this transaction and before deciding to acquire the Shares, Recipient
has been provided with financial and other written information about the Company. Recipient has been given the opportunity by the
Company to obtain any information and ask questions concerning the Company, the Shares, and Recipient’s investment that Recipient
felt necessary; and to the extent Recipient availed himself of that opportunity, Recipient has received satisfactory information
and answers.

 

(g) No
Legal Advice from Company or its Legal Counsel. Except for any statements or representations of the Company made in this Agreement
and the other agreements entered into between the parties hereto, Recipient is relying on its own review of this Agreement and
the other agreements entered into between the parties and not on any statements or representations of the Company or any of its
representatives or agents or legal counsel for legal, tax or investment advice with respect to this investment, the transactions
contemplated by this Agreement or the securities laws of any jurisdiction.

 

    -2-

     

    

 

(h) Risks.
Recipient acknowledges and understands that (i) an investment in the Company constitutes a high risk, (ii) the Shares
are highly speculative, and (iii) there can be no assurance as to what investment return, if any, there may be. Recipient
is aware that the Company may issue additional securities in the future which could result in the dilution of Recipient’s
ownership interest in the Company.

 

(i) Valid
Agreement. This Agreement when executed and delivered by Recipient shall constitute a valid and legally binding obligation
of Recipient which is enforceable in accordance with its terms.

 

(j) Legend.
Recipient acknowledges and agrees that the Shares shall bear restricted legends, in the form and substance as set forth in Section
3.3 hereof, prohibiting the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration
statement filed under the Securities Act, (ii) in accordance with the applicable provisions of Regulation S, promulgated under
the Securities Act, (iii) pursuant to an exemption from registration provided by Rule 144 under the Securities Act (if available),
and (iv) pursuant to any other exemption from the registration requirements of the Securities Act.

 

3.3 Restrictive
Legends. In order to reflect the restrictions on the disposition of the Shares, the stock certificates for the Shares will
be endorsed with restrictive legends, including the following legends:

 

(a) “THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND
MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE
OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE
COMPLIES WITH THE ACT.

 

THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO A VESTING SCHEDULE AS SET FORTH IN A RESTRICTED STOCK GRANT AGREEMENT BETWEEN THE ISSUER AND
THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH VESTING SCHEDULE
IS BINDING ON TRANSFEREES OF THESE SHARES.”

 

(b) If
required by the authorities of any state in connection with the issuance of the Shares, the legend or legends required by such
state authorities shall also be endorsed on all such certificates.

 

    -3-

     

    

 

4. General
Provisions.

 

4.1 Notices.
Any notice given in connection with this Agreement shall be given in writing and shall be deemed effective upon personal delivery,
upon deposit with a nationally recognized courier service, or upon deposit in the United States mail, registered or certified,
postage prepaid and addressed to the party entitled to such notice at the address indicated below such party’s signature
line on this Agreement or at such other address as such party may designate by ten (10) days advance written notice under this
Section to all other parties to this Agreement.

 

4.2 No
Waiver. The failure of the Company (or its assignees) in any instance to exercise any right hereunder shall not constitute
a waiver of any other rights that may subsequently arise under the provisions of this Agreement or any other agreement between
the Company and Recipient. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or
subsequent breach or condition, whether of like or different nature.

 

4.3 Adjustment
for Stock Split. All references to the number of Shares in this Agreement shall be adjusted to reflect any stock split, stock
dividend or other change in the Shares which may be made after the date of this Agreement.

 

5. Miscellaneous
Provisions.

 

5.1 Recipient
Undertaking. Recipient hereby agrees to take whatever additional action and execute whatever additional documents the Company
may in its judgment deem necessary or advisable in order to carry out the obligations or restrictions imposed on Recipient under
this Agreement.

 

5.2 No
Other Interest. Recipient confirms that except for the shares of Common Stock of the Company granted to Recipient pursuant
to this Agreement, Recipient does not have the right to purchase or otherwise receive any Common Stock of the Company. Any prior
agreements with respect thereto are hereby rendered null and void.

 

5.3 Entire
Agreement. This Agreement constitutes the entire agreement between the parties hereto with regard to the subject matter hereof.

 

5.4 Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Nevada, as such laws are
applied to contracts entered into and performed in such State.

 

5.5 Severability.
Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions shall nevertheless remain
effective and shall remain enforceable to the greatest extent permitted by law.

 

5.6 Counterparts.
This Agreement may be executed in counterparts, including by facsimile or PDF via electronic mail, each of which shall be deemed
to be an original, but all of which together shall constitute one and the same instrument.

 

5.7 Successors
and Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company and its successors
and assigns and Recipient and Recipient’s legal representatives, heirs, legatees, distributees, assigns and transferees by
operation of law, whether or not any such person shall have become a party to this Agreement and have agreed in writing to join
herein and be bound by the terms and conditions hereof.

 

[Signature Page Follows]

 

    -4-

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Restricted Stock Grant Agreement as of the date first set forth above.

 

	 	COMPANY:
	 	 	 
	 	AVANT
    DIAGNOSTICS INC.
	 	 	 
	 	By:	/s/ Gerald Commissiong
	 	Name:	Gerald Commissiong
	 	Title:	Executive
Director
	 	Address:	8561
    East Anderson Drive, Suite 104
	 	 	Scottsdale,
    AZ 85225
	 	 	 
	 	RECIPIENT:
	 	 	 
	 	/s/ Gregg Linn
	 	Gregg Linn
		Address:	10994
    East Beck Lane
	 	 	Scottsdale,
    AZ  85225

 

 

 

-Signature Page-Exhibit 10.17

 

SECOND
AMENDED AND RESTATED

CONFIDENTIAL
SETTLEMENT AGREEMENT

 

This
Second Amended and Restated Confidential Settlement Agreement (“Agreement”) is made and entered into on September
19, 2017 (the “Settlement Effective Date”) by and between the undersigned parties, Memory DX, LLC (“Plaintiff”),
Amarantus Bioscience Holdings, Inc. (the “Company”) and Avant Diagnostics, Inc. (“Avant”). Plaintiff,
Avant and the Company are referred to individually as “Party” and collectively as “Parties” in this Agreement.

 

RECITALS

 

A.  On
or about September 16, 2016, Plaintiff filed a lawsuit against the Company, Amarantus Bioscience, Inc., Amarantus Diagnostics,
Inc., Avant Diagnostics, Inc., Avant Diagnostics Acquisition Corporation, et al (collectively the “Defendants”) in
the Superior Court of the State of Arizona, County of Maricopa (Case Number CV2016-015026) (the “Action”). On or about
November 4, 2016, Plaintiff filed an Application for Entry of Default with the Superior Count of the State of Arizona, County
of Maricopa. On or about December 14, 2016, a default judgment (the “Default Judgment”) was rendered in Case Number
CV2016-015026 and was entered in Superior Court of the State of Arizona, County of Maricopa against the Defendants.

 

B.  On
or about February 15, 2017, the Parties entered into a Confidential Settlement Agreement (the “First Agreement”) to
fully and finally satisfy the Default Judgment.

 

C.  On
or about May 25, 2017, the Parties amended and restated the First Agreement (the “Second Agreement”) to fully and
finally satisfy the Default Judgment.

 

D.  The
Defendants now wish to amend and restate the Second Agreement to fully and finally satisfy the Default Judgement and the Plaintiff
has agreed to accept certain consideration in order to fully and finally satisfy their obligations under the Default Judgment.
This Agreement memorializes the Parties’ agreement regarding their settlement and supersedes the replaces in its entirety
the Second Agreement.

 

    	 	-1-	 

     

    

 

NOW,
THEREFORE, in consideration of the terms, conditions, and promises set forth herein, the sufficiency of which is hereby acknowledged
by both Parties, and incorporating the Recitals set forth above, the Parties agree to amended and restate the Second Agreement
as follows:

 

1.  Consideration
by Defendants.

 

1.1.  In
consideration for fully satisfying the Default Judgment, Avant will pay Plaintiff an aggregate of $250,000 (the “Cash Consideration”)
as follows: (i) a payment of $35,000 which has been paid and received by Plaintiff on or prior to the date hereof, (ii) $3,500
will be paid upon execution of this Agreement, (iii) $2,000 will be payable on the last calendar day of each month for October
and November 2017, (iv) $5,000 will be payable on the last calendar day of each month for December 2017 and each of January and
February 2018 and (v) $10,000 will be payable on the last calendar day of each month beginning in the month of March 2018 through
the last month in which the Settlement Sum is paid in full. Notwithstanding the foregoing in this subsection, upon the sale by
Avant of its equity securities in a single offering for aggregate gross proceeds of at least $7,500,000 (the “Qualified
Offering”) after the date of the Agreement, Avant will pay any remaining amount of the Cash Consideration then outstanding
upon the final closing of such Qualified Offering. The Company will have ten (10) calendar days to deliver the final payment of
the balance owed after the closing of the Qualified Offering.

 

1.2.  The
Plaintiff acknowledges that Avant has issued to Plaintiff 5,000,000 restricted shares of common stock (the “Initial Shares”)
of Avant on or prior to the date of this Agreement as partial consideration for the Default Judgment but Plaintiff has disputed
that the issuance complied with the Agreement. Defendants agree to reissue the Initial Shares to reflect a correct issue date
of May 10, 2017. In addition, Avant will issue to Plaintiff an additional 5,000,000 restricted shares of common stock reflecting
an issue date of September 15, 2017 (the “Additional Shares”). Together with the issuance of the corrected Initial
Shares, and the Cash Consideration, the issuance of the Additional Shares constitutes the remaining consideration (collectively,
the “Settlement Sum”) for the removal of the Default Judgment. Plaintiff agrees that the Additional Shares certificate
may be held by counsel for Defendants in trust until receipt of proof of the removal of the Default Judgment.

 

1.3.  Upon
payment by the Company of the Settlement Sum, Plaintiff shall assign the License Agreement between Plaintiff and University of
Leipzig dated May 22, 2013, as amended, to Avant, as well as also assign the Asset Purchase Agreement between Plaintiff and Company
to Avant.

 

    	 	-2-	 

     

    

 

1.4.  For
a period of two years from the date of this Agreement, if the Company shall determine to file with the Securities and Exchange
Commission (the “SEC”), a registration statement relating to an offering for its own account or the account of others
under the Securities Act or 1933, as amended (the “Securities Act”) of any of its equity securities (other than on
Form S-4 or Form S-8 or their then equivalents relating to equity securities issued solely in connection with any acquisition
of any entity or business or equity securities issuable in connection with stock option or other employee benefit plans), the
Company shall send to the Plaintiff written notice of such determination and, if within ten (10) days after the date of such notice,
the Plaintiff shall so request in writing, the Company shall include in such registration statement all or any part of Shares
that Plaintiff requests to be registered. Subject to the terms of this Agreement, the Company shall use its commercially reasonable
efforts to keep such registration statement continuously effective under the Securities Act, until the first to occur of: (A)
the date that is one (1) year from the date the registration statement is declared effective by the SEC and (B) the date that
all Shares covered by such registration statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold
without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144 (the “Effectiveness Period”). Notwithstanding the registration
obligations set forth in this Section, if the SEC informs the Company that all of the Shares cannot, as a result of the application
of Rule 415 promulgated under the Securities Act, be registered for resale on a single registration statement, the Company agrees
to promptly inform Plaintiff and use its commercially reasonable efforts to file amendments to any registration statement as required
by the SEC, covering the maximum number of Shares permitted to be registered by the SEC, on Form S-1 or such other form available
to register for resale the Shares; provided, however, that prior to filing such amendment, the Company shall be
obligated to use diligent efforts to advocate with the SEC for the registration of all of the Shares in accordance with any (i)
any publicly-available written or oral guidance of the SEC staff, or any comments, requirements or requests of the SEC staff and
(ii) the Securities Act (collectively, “SEC Guidance”), including without limitation, Compliance and Disclosure Interpretation
612.09. Notwithstanding any other provision of this Agreement, if the SEC or any SEC Guidance sets forth a limitation on the number
of Shares permitted to be registered on a particular registration statement (and notwithstanding that the Company used diligent
efforts to advocate with the Commission for the registration of all or a greater portion of Shares), unless otherwise directed
in writing by Executive as to its Shares, the number of Shares to be registered on such Registration Statement will be reduced
to such amount as allowed under SEC Guidance. In the event of a cutback hereunder, the Company shall give the Executive at least
five (5) business days prior written notice. In the event the Company amends the registration statement in accordance with the
foregoing, the Company will use its commercially reasonable efforts to file with the SEC, as promptly as allowed by the SEC or
SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-1
or such other form available to register for resale those Shares that were not registered on any prior registration statement
filed with the SEC. In addition, if any rights granted pursuant to this Section involves the inclusion of securities in connection
with an underwritten offering, and the managing underwriter (or, in the case of an offering that is not underwritten, an investment
banker) shall advise the Company that, in its opinion, the number of securities requested and otherwise proposed to be included
on such registration statement exceeds the number which can be sold in such offering without adversely affecting the marketability
of the offering, the Company will include in such Registration to the extent of the number which the Company is so advised can
be sold in such offering, first, the securities the Company proposes to sell for its own account on such registration statement
and second, the Shares of the Plaintiff requesting to be included on such registration statement and all other securities
requested to be included in such registration statement on a pro rata basis.

 

2.  Entire
Consideration.  Plaintiff agrees that the Settlement Sum shall constitute the entire consideration due to it and, when paid
and performed, is in full and complete satisfaction of the Default Judgment, and that Plaintiff will not seek any further compensation
for any other claimed damages, costs, or attorneys’ fees in connection with the matters encompassed in this Agreement.

 

    	 	-3-	 

     

    

 

3.  Removal
of Default Judgment. Within three (3) business days of the issuance of the Additional Shares, Plaintiff shall take all necessary
action to withdraw the recorded Default Judgment. The Default Judgment shall be set aside without prejudice and shall provide
written evidence of such to the Defendants. Upon a default by Defendants of its obligations to timely pay the Settlement Sum,
in accordance with the requirements and deadlines as set forth above, after written notice and five (5) business days to cure
said default, Plaintiff will be entitled to reinstate the Default Judgment. Defendants agree to promptly execute such documents
as are necessary to permit the reinstatement of the Default Judgment, including a stipulation to reinstate the Default Judgment
or other documents reasonably required to effectuate the terms of this Agreement.

 

4.  
Mutual Releases. Effective upon the Settlement Effective Date, and in consideration of the terms and conditions of this
Settlement Agreement, the Company, on the one hand, and Plaintiff on the other hand, generally, fully and completely release and
forever discharge each other and all of their officers, employees, stockholders, affiliated entities, agents, representatives,
attorneys, and their respective successors, heirs and assigns, from any and all claims, demands, obligations, causes of action,
damages, and liabilities of every kind and nature, in law, equity, or otherwise, known or unknown, suspected or unsuspected, disclosed
or undisclosed, contingent or matured, which any of the Parties now has or had in connection with any actions, omissions or conduct
of any type occurring prior to the Settlement Effective Date, including but not limited to the matters underlying the Default
Judgment, whether based on tort, contract, indemnification, contribution, subrogation or any other theory of recovery and whether
for compensatory or punitive damages, whether known or unknown; provided, however, that nothing shall release the rights or claims
of the Parties under this Settlement Agreement.

 

5.  Successors.
This Agreement shall be binding upon the Parties, and their heirs, representatives, executors, administrators, successors, insurers,
and assigns, and shall inure to the benefit of each of the Plaintiff and the Company, and to their respective representatives,
administrators, successors, and subsequent assignees.

 

6.  No
Attorneys’ Fees and Costs. The Parties agree that except as otherwise stated herein, they shall bear their own respective
costs and fees, including but not limited to attorneys’ fees.

 

7.  Ownership
of Claims and Event of Breach. Plaintiff represents that it has not transferred or assigned, or purported to transfer or assign,
to any person or entity, any judgment or claim described in this Agreement. In the event Defendants
fail to make payment of any portion of the Cash Consideration within seven (7) calendar days of when any payment is due, Plaintiffs
retain the right to reinstate the Default Judgement and Plaintiff shall have the right to
file suit for breach of this Agreement and/or injunctive relief and, if successful, be entitled to recovery of all reasonable
attorneys’ fees and costs incurred in the action. In the event, Plaintiff breaches Section 3 of this Agreement, Plaintiff
will immediately pay the Company any portion of the Settlement Sum received by Plaintiff and Defendants
have the right to file suit for breach of this Agreement and demand damages and/or injunctive relief and, if successful, be entitled
to recovery of all reasonable attorneys’ fees and costs incurred in the action.

 

    	 	-4-	 

     

    

 

8.  Governing
Law. This Agreement shall be governed by and interpreted under the laws of the State of Arizona applicable to contracts made
and to be performed entirely within such State.

 

9.  Entire
Agreement. This Agreement sets forth the entire agreement between the Parties and fully supersedes any and all prior agreements
and understandings between the Parties pertaining to the subject matter of this Agreement. The Parties agree that no change to
or modification of this Settlement Agreement shall be valid or binding unless it is in writing and signed by the Parties.

 

10.  Construing
Provisions. The language of all parts in this Agreement shall be construed as a whole, according to its fair meaning, and
not strictly for or against either Party. Should any provision in this Agreement be declared or determined to be illegal or invalid,
the validity of the remaining parts, terms, or provisions shall not be affected and the illegal or invalid part, term, or provision
shall be deemed not to be part of this Agreement, and all remaining provisions shall remain valid and enforceable. Plaintiff further
agrees that in the event any provision of this Agreement is held to be illegal or unenforceable, Plaintiff will fully cooperate
with the Company to effectuate its purpose to conform the provision(s) to law.

 

11.  Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Furthermore, signatures delivered via facsimile transmission shall have the same
force and effect as the originals thereof.

 

12.  Severability.
The various provisions of this Agreement are severable. Should any provision of this Agreement be declared or be determined
by any court of competent jurisdiction to be illegal, invalid, or unenforceable, the legality, validity, and enforceability of
the remaining parts, terms, or provisions shall not be affected thereby, and said offending term or provision shall be deemed
severed (i.e. deemed not a part of this Agreement).

 

    	 	-5-	 

     

    

 

Having
read the foregoing, having fully understood and agreed to the terms and provisions of this Agreement, the Parties voluntarily
and of their own free will execute this Agreement.

 

	Date:
    September 19, 2017	/s/
    William Gartner
	 	Memory
    DX, LLC
	 	By:
      William Gartner
	 	Title:
    Managing Partner
	 	 
	Date:
    September 19, 2017	/s/
    Gerald Commissiong
	 	Amarantus
    BioScience Holdings, Inc.
	 	By:
  Gerald Commissiong
	 	Title:
    CEO
	 	 
	 Date:
    September 19, 2017	/s/
Philippe Goix
		Avant
    Diagnostics, Inc.
	 	By:
       Philippe Goix
	 	Title:
    CEO

 

 

-6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]